Ask AI

ClinicalThought

Share

Program Content

Activities

  • IL-13 Inhibition for Atopic Dermatitis
    Addressing the Burden of Atopic Dermatitis: IL-13 Inhibition for Moderate to Severe Disease
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 28, 2025

    Expires: August 27, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange and Smart Patients.

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange, LLC

ProCE Banner

Smart Patients

ProCE Banner